D-0620-2018 Class II Terminated

Recalled by Teva Pharmaceuticals USA — North Wales, PA

Recall Details

Product Type
Drugs
Report Date
March 28, 2018
Initiation Date
March 19, 2018
Termination Date
October 15, 2019
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
640,486 vaginal inserts

Product Description

Estradiol Vaginal Inserts, USP 10 mcg, packaged in a) 8 inserts/carton (NDC 0093-3223-08) and b) 18 inserts/carton (NDC 0093-3223-97), Rx only, Teva Women's Health, Inc. Subsidiary of Teva Pharmaceuticals USA, North Wales, PA 19454.

Reason for Recall

Defective Container: This recall is being initiated due to product complaints regarding difficulty in dispensing the tablet from the applicator.

Distribution Pattern

Distributed within the United States and Puerto Rico.

Code Information

Lot #: a) 33812545A, 33812546A, 33812774A, Exp. 12/2018; 33812775A, Exp. 01/2019; 33812776A, 33812777A, Exp. 05/2019; 33813786A, 33813868A, Exp. 7/2019; 33813974A, 33814058A, Exp. 09/2019; 33814113A, Exp. 01/2019; b) 33812547A, 33813361A,33813676A, Exp. 1/2019